|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/16 | (2006.01) |
| A61K 31/18 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3644970 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18737225.5 |
| Date of filing the European patent application | 2018-06-29 | |
| (97) | Date of publication of the European application | 2020-05-06 |
| (45) | Date of publication and mention of the grant of the patent | 2022-02-09 |
| (46) | Date of publication of the claims translation | 2022-04-25 |
| (86) | Number | PCT/EP2018/067717 |
| Date | 2018-06-29 |
| (87) | Number | WO 2019/002614 |
| Date | 2019-01-03 |
| (30) | Number | Date | Country code |
| 201762527684 P | 2017-06-30 | US | |
| 17305853 | 2017-07-03 | EP |
| (72) |
PIVETTE, Perrine , FR
LEMARCHAND, Caroline , FR
YATES, Ian , US
BLOOM, Corey , US
|
| (73) |
ACROTECH BIOFARMA LLC,
279 Princenton Highstown Road East Windsor, NJ 08520,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Naujos peroralinės belinostato vaistinės formos |
| NEW ORAL FORMULATIONS OF BELINOSTAT |
| Payment date | Validity (years) | Amount | |
| 2025-06-02 | 8 | 185.00 EUR |
| 2026-06-29 |